0 Σχόλια
0 Μοιράστηκε
343 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Aβ-Protein Inhibitors Reshaping Alzheimer’s Disease Treatment and Drug DevelopmentThe Changing Alzheimer’s Disease Treatment Landscape Alzheimer’s disease treatment has increasingly shifted from managing symptoms toward disease modification, particularly with therapies designed to target amyloid-beta (Aβ), a protein associated with plaque accumulation in the brain. The development of amyloid beta inhibitors has provided clinical evidence that removing...0 Σχόλια 0 Μοιράστηκε 946 Views 0 Προεπισκόπηση
-
Alzheimer's Disease Diagnostic Market - Artificial Intelligence and Biomarker InnovationMarket Overview Artificial intelligence and biomarker innovation represent transformative capabilities advancing Alzheimer's diagnostics through machine learning analysis, novel biomarker identification, and predictive analytics enabling earlier detection and personalized disease assessment. The Alzheimer's Disease Diagnostic Market transformation toward AI sophistication substantially advance...0 Σχόλια 0 Μοιράστηκε 841 Views 0 Προεπισκόπηση
-
Alzheimer's Drugs Lead Prescription Drug Demand with 21.7% Market Share in 2025Prescription Drugs Market to Reach USD 2.36 Trillion by 2034, Growing at 7.1% CAGR: Polaris Market Research According to a new report by Polaris Market Research, the global prescription drugs market was valued at USD 1.27 trillion in 2025 and is estimated at USD 1.35 trillion in 2026. It is projected to reach USD 2.36 trillion by 2034, expanding at a CAGR of 7.1% from 2026 to 2034. Growth is...0 Σχόλια 0 Μοιράστηκε 489 Views 0 Προεπισκόπηση
-
Alzheimer's Drugs Market Size, Share, Growth Trends and Forecast 2031The growing prevalence of Alzheimer’s disease, combined with a rapidly aging global population, is increasing the demand for effective therapeutic solutions. Advances in disease-modifying treatments, early diagnosis, and neuroscience research are also reshaping treatment approaches. The Alzheimer's Drugs Market is projected to grow from US$ 8.24 billion in 2024 to US$ 26.37 billion by...0 Σχόλια 0 Μοιράστηκε 461 Views 0 Προεπισκόπηση
-
Alzheimer's Therapeutics Market: Where Biopharma Leaders Are Investing for the Next DecadeAlzheimer's Therapeutics Market According to the latest report published by Data Bridge Market Research, the Alzheimer's Therapeutics Market Alzheimer’s therapeutics market was valued at USD 5.99 billion in 2024 and is expected to reach USD 11.39 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Alzheimer’s Diagnosis and Drugs Market: Key Trends Transforming Dementia CareThe Alzheimer’s Diagnosis and Drugs Market is evolving rapidly as healthcare systems place greater emphasis on early detection, accurate disease identification, and therapies capable of addressing disease progression. Growing investment in neurological research, biomarker-based diagnostics, and innovative treatment approaches is creating new opportunities across the healthcare ecosystem....0 Σχόλια 0 Μοιράστηκε 226 Views 0 Προεπισκόπηση
-
Alzheimer’s Disease Diagnostic Market – Early Detection Drives InnovationThe Alzheimer’s disease diagnostic market is expanding as ageing populations, rising dementia prevalence, greater awareness, and advances in biomarkers and imaging increase the need for earlier and more accurate assessment. The market was valued at USD 10.26 billion in 2024 and is projected to reach USD 26.64 billion by 2035, growing at a CAGR of 9.02%. Alzheimer’s disease is the...0 Σχόλια 0 Μοιράστηκε 338 Views 0 Προεπισκόπηση
-
Alzheimer’s Disease Diagnostic Market: Blood-Based Biomarkers, Amyloid PET Imaging, and Early Neuro-degeneration Screening Driving GrowthSurging global prevalence of neurodegenerative disorders, expanding clinical availability of disease-modifying anti-amyloid therapies, and continuous technological refinements in high-sensitivity immunoassay platforms are driving rapid growth across the global Alzheimer’s Disease Diagnostic Market. Alzheimer's disease diagnostic tools—comprising blood-based biomarker assays (such as...0 Σχόλια 0 Μοιράστηκε 195 Views 0 Προεπισκόπηση
-
Alzheimer’s Therapeutics Market Forecast Highlights Innovation in Alzheimer’s Drug DevelopmentAccording to Future Market Insights (FMI), the global Alzheimer’s therapeutics market is projected to expand from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, registering a 9.2% CAGR during the forecast period. The market was valued at USD 3.9 billion in 2025, creating an incremental opportunity of approximately USD 6.5 billion through 2036. Donepezil is expected to account for...0 Σχόλια 0 Μοιράστηκε 575 Views 0 Προεπισκόπηση
-
Alzheimer’s Therapeutics Market: Global Outlook, Trends, and Growth ForecastThe global Alzheimer’s therapeutics market is projected to reach USD 10.4 billion by 2036, up from USD 4.3 billion in 2026, registering a compound annual growth rate (CAGR) of 9.2% over the forecast period, according to Future Market Insights (FMI). The market was valued at USD 3.9 billion in 2025, reflecting the growing commercial importance of prescription treatments for...0 Σχόλια 0 Μοιράστηκε 213 Views 0 Προεπισκόπηση
-
Cerebrospinal Fluid (CSF) Analysis and Mass Spectrometry in the Alzheimer’s Disease Diagnostic MarketRefining mass spectrometry reference methods and automated cerebrospinal fluid (CSF) biomarker assays is maintaining diagnostic gold standards in the Alzheimer’s Disease Diagnostic Market. Multiplexed CSF assays quantify amyloid-beta, total tau, and neurofilament light chain (NfL) simultaneously from a single lumbar puncture sample, evaluating neurodegeneration severity and...0 Σχόλια 0 Μοιράστηκε 248 Views 0 Προεπισκόπηση
-
Neurological Biomarkers Market Growth Accelerates with Precision NeurologyThe neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
CNS Biomarkers Market Size, Trends, and Outlook Through 2033The global central nervous system biomarkers market size was valued at USD 5.37 billion in 2024 and is projected to grow USD 5.84 billion in 2025 to USD 11.34 billion by 2033, growing at a CAGR of 8.66% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Central Nervous System Biomarkers Market Growth by...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Complete Home Patient Care Guide: Patient Care Services in Central Delhi and Noida ExtensionHome healthcare has transformed the way families care for their loved ones. Instead of spending long periods in hospitals, patients can now receive compassionate and professional care in the comfort of their own homes. This approach promotes faster recovery, reduces stress, and allows patients to remain close to family members during the healing process. Professional home caregivers provide...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Evaluating Market Sizing & CAGR Expectations for Next-Generation Alzheimer’s BiologicsMarket Overview The Alzheimer's therapeutics market encompasses pharmaceutical formulations, biological agents, and novel pipeline compounds designed to slow cognitive decline, manage behavioral symptoms, and target underlying disease pathology. Valued robustly on a multi-billion-dollar scale, the market is projected to experience accelerated growth through the next decade, fueled by...0 Σχόλια 0 Μοιράστηκε 128 Views 0 Προεπισκόπηση
-
Global Alzheimer’s Disease Treatment Market Outlook: 20% CAGR Through 2034According to The Insight Partners, The Alzheimers Disease Treatment Market is anticipated to expand at a CAGR of 20% from 2026 to 2034. Market conditions continue to evolve, leading to new opportunities for stakeholders. The overall landscape reflects stable progress and long-term growth potential. The Alzheimer’s Disease Treatment Market is expected to experience significant growth...0 Σχόλια 0 Μοιράστηκε 133 Views 0 Προεπισκόπηση
-
Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Mild Cognitive Impairment (MCI) Treatment Market Size, Share, Growth & Forecast 2034According to the latest report published by Data Bridge Market Research, the Mild Cognitive Impairment (MCI) Treatment Market CAGR ValueAs per Data Bridge Market Research Analysis the global mild cognitive impairment (MCI) treatment market size was valued at USD 2.51 billion in 2025 and is expected to reach USD 4.89 billion by 2033, at a CAGR of 8.70% during the forecast period....0 Σχόλια 0 Μοιράστηκε 211 Views 0 Προεπισκόπηση
-
Patient Care Services in Central Delhi and Defence Colony for Comfortable Home RecoveryRecovering at home can be a comfortable option for patients who need assistance with daily activities but do not require continuous hospital admission. Elderly people, patients returning from the hospital, individuals with limited mobility, and bedridden patients may need regular help with personal care, meals, movement, and companionship. Professional home caregivers can provide this support...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων